2,217
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors

, , , , , , , , , , & show all
Pages 1632-1650 | Received 08 Mar 2021, Accepted 22 May 2022, Published online: 07 Jun 2022

References

  • Jiménez C. Marine natural products in medicinal chemistry. ACS Med Chem Lett 2018;9:1632–61.
  • Bharate SB, Sawant SD, Singh PP, Vishwakarma RA. Kinase inhibitors of marine origin. Chem Rev 2013;113:6761–815.
  • Marston A. Natural products as a source of protein kinase activators and inhibitors. Curr Top Med Chem 2011;11:1333–9.
  • Nakano H, Omura S. Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine. J Antibiot 2009;62:17–26.
  • Knapper S, Burnett AK, Littlewood T, et al. A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy. Blood 2006;108:3262–70.
  • Hexner EO, Serdikoff C, Jan M, et al. Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders. Blood 2008;111:5663–71.
  • Wick W, Puduvalli VK, Chamberlain MC, et al. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol 2010;28:1168–74.
  • Routier S, Coudert G, Mérour J-Y. Synthesis of naphthopyrrolo[3,4-c]carbazoles. Tetrahedron Lett 2001;42:7025–8.
  • Bourderioux A, Kassis P, Mérour J-Y, Routier S. Synthesis of new fused and substituted benzo and pyrido carbazoles via C-2 (het)arylindoles. Tetrahedron 2008;64:11012–9.
  • Lefoix M, Coudert G, Routier S, et al. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors. Bioorg Med Chem 2008;16:5303–21.
  • Routier S, Mérour J-Y, Dias N, et al. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents. J Med Chem 2006;49:789–99.
  • Routier S, Peixoto P, Mérour JY, et al. Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents. J Med Chem 2005;48:1401–13.
  • Bourderioux A, Routier S, Bénéteau V, Mérour J-Y. Synthesis of benzo analogs of oxoarcyriaflavins and caulersine. Tetrahedron 2007;63:9465–75.
  • Bourderioux A, Bénéteau V, Mérour J-Y, et al. Synthesis and biological evaluation of novel oxophenylarcyriaflavins as potential anticancer agents. Org Biomol Chem 2008;6:2108–17.
  • Neagoie C, Vedrenne E, Buron F, et al. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: A novel DYRK1A inhibitor class. Eur J Med Chem 2012;49:379–96.
  • Fan H, Peng J, Hamann MT, Hu J-F. Lamellarins and related pyrrole-derived alkaloids from marine organisms. Chem Rev 2008;108:264–87.
  • Youssef DTA, Almagthali H, Shaala LA, Schmidt EW. Secondary metabolites of the genus didemnum: a comprehensive review of chemical diversity and pharmacological properties. Mar Drugs 2020;18:307.
  • Baunbaek D, Trinkler N, Ferandin Y, et al. Anticancer alkaloid lamellarins inhibit protein kinases. Mar Drugs 2008;6:514–27.
  • Zhang T-Y, Liu C, Chen C, et al. Copper-mediated cascade C-H/N-H annulation of indolocarboxamides with arynes: construction of tetracyclic indoloquinoline alkaloids. Org Lett 2018;20:220–3.
  • Li Z, Wang W, Zhang X, et al. One-pot synthesis of indolo[2,3-c]quinolin-6-ones by sequential photocyclizations of 3-(2-Azidophenyl)-N-phenylacrylamides. Synlett 2012;24:73–8.
  • Szabó T, Papp M, Németh DR, et al. Synthesis of indolo[2,3-c]quinolin-6(7H)-ones and antimalarial Isoneocryptolepine. Computational study on the Pd-catalyzed intramolecular C–H arylation. J. Org. Chem 2021;86:128–45
  • Gu C-X, Chen W-W, Xu B, Xu M-H. Synthesis of indolo[2,3-c]coumarins and indolo[2,3-c]quinolinones via microwave-assisted base-free intramolecular cross dehydrogenative coupling. Tetrahedron 2019;75:1605–11.
  • Chen Z, Wang X. A Pd-catalyzed, boron ester-mediated, reductive cross-coupling of two aryl halides to synthesize tricyclic biaryls. Org Biomol Chem 2017;15:5790–6.
  • Sakamoto T, Nagano T, Kondo Y, Yamanaka H. Palladium-catalyzed coupling reaction of 3-iodoindoles and 3-iodobenzo[b]thiophene with terminal acetylenes. Chem Pharm Bull 1988;36:2248–52.
  • Collibee SE, Yu J. A facile and convenient synthesis of functionalized ortho-nitrophenylboronic acids. Tetrahedron Lett 2005;46:4453–5.
  • Elie J, Feizbakhsh O, Desban N, et al. Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation. J Enzyme Inhib. Med. Chem 2020;35:1840–53.
  • Feizbakhsh O, Place M, Fant X, et al. The mitotic protein kinase haspin and its inhibitors. In: Prignet C, ed. Protein phosphorylation. Ch. 02. Rijeka: InTech; 2017.
  • Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem 2006;49:6177–96.
  • Halgren TA, Murphy RB, Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004;47:1750–9.
  • Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49.
  • Schrödinger release 2019-1: Glide. New York, NY: Schrödinger, LLC; 2020.
  • Nguyen T-N-D, Feizbakhsh O, Sfecci E, et al. Kinase-based screening of marine natural extracts leads to the identification of a cytotoxic high molecular weight metabolite from the Mediterranean Sponge Crambe tailliezi. Mar. Drugs 2019;17:569.
  • Marvin 20.13.10, 2020 ChemAxon. http://www.chemaxon.com.
  • Gally JM, Bourg S, Fogha J, et al. VSPrep: A KNIME workflow for the preparation of molecular databases for virtual screening. Curr Med Chem 2019;27:6480–6494.
  • Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42.
  • Anderson K, Chen Y, Chen Z, et al. Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors. Bioorg Med Chem Lett 2013;23:6610–5.